Publications by authors named "Junichi Yamaguchi"

Marked first-degree atrioventricular block with a PR interval ≥500 ms is rare, leading to unusual P-wave placement. In this case, the P waves immediately after the QRS waves complicated rhythm interpretation. Close attention to P-wave morphology and fused premature ventricular complexes can be important for a proper diagnosis.

View Article and Find Full Text PDF

Background: A small mitral valve area (MVA) is one of the challenging anatomies for transcatheter edge-to-edge repair (TEER) for mitral regurgitation, but the relationship between baseline MVA and clinical outcomes remains unknown. This study aimed to evaluate the association of baseline MVA with procedural and clinical outcomes in patients undergoing TEER with MitraClip from the OCEAN-Mitral registry (Optimized Catheter Valvular Intervention-Mitral).

Methods: A total of 1768 patients undergoing TEER were divided into 3 groups according to baseline MVA: group 1: <4.

View Article and Find Full Text PDF

Background: A wearable cardioverter defibrillator (WCD) is indicated for a limited period in patients at high risk of sudden cardiac death (SCD). Nonischemic heart failure (HF) is common among Japanese patients with HF. The aim of this study was to evaluate the incidence of fatal arrhythmias during WCD use and the clinical outcomes after WCD withdrawal in Japanese patients with HF.

View Article and Find Full Text PDF

The efficacy and safety of percutaneous coronary intervention (PCI) for coronary artery disease has been established, and approximately 250,000 PCI procedures are performed annually in Japan. However, various complications including life-threatening complications can occur during PCI. Although several bailout procedures have been proposed to address complications during PCI, it is critically important for operators to manage each complication in real catheter rooms with confidence even in emergent situations.

View Article and Find Full Text PDF
Article Synopsis
  • This study explores the relationship between handgrip strength and all-cause mortality in patients undergoing transcatheter edge-to-edge repair (TEER) for heart issues, suggesting that weaker grip strength could indicate a higher risk of death post-procedure.
  • It includes data from the OCEAN-Mitral Registry, which analyzed handgrip tests of 2077 patients before TEER, with follow-ups showing varied changes in strength based on the success of the procedure.
  • The findings suggest that improving mitral regurgitation (MR) post-TEER can positively impact frailty and resilience, making this research a significant insight into patient outcomes in heart-related treatments.
View Article and Find Full Text PDF
Article Synopsis
  • This study examined how left ventricular ejection fraction (LVEF) changes after a specific heart valve repair procedure called transcatheter edge-to-edge valve repair (TEER) in patients with mitral regurgitation (MR).
  • Findings revealed that 32% of patients experienced worsened LVEF after the procedure, linked to increased end-systolic volumes in the heart and certain predictors like higher LVEF and levels of B-type natriuretic peptide.
  • Despite the LVEF worsening, long-term outcomes (like death or hospitalization for heart failure) were similar for both patients with worsened and preserved LVEF, indicating that LVEF change might not significantly impact overall health results post-TEER
View Article and Find Full Text PDF

In patients with heart failure (HF) with reduced left ventricular ejection fraction (HFrEF), low tricuspid annular plane systolic excursion (TAPSE) on echocardiography is associated with poor prognosis. The significance of TAPSE changes post-HF treatment among HFrEF patients remains unclear. We evaluated the factors associated with persistently low TAPSE and its prognostic impact in Japanese hospitalized patients with HFrEF.

View Article and Find Full Text PDF

Background: The Clinical Frailty Scale (CFS) is a useful frailty marker for predicting clinical outcomes in patients undergoing invasive therapy. However, the clinical impact of CFS after transcatheter edge-to-edge repair in patients with mitral regurgitation (MR) remains unclear. This study aimed to elucidate the association between the baseline frail status defined by the CFS and clinical outcomes with or without postprocedural MR ≥2+ (post-MR ≥2+) after transcatheter edge-to-edge repair.

View Article and Find Full Text PDF

Background: Various surgical procedures have employed microporous polysaccharide hemosphere (MPH) hemostatic agents. However, data regarding their effectiveness in preventing pocket hematomas (PHs) during the implantation of cardiac implantable electronic devices (CIED) among the Asian population are limited. Therefore, this study aimed to investigate the potential benefits of using MPH hemostatic agents during CIED implantations as a preventive measure against post-procedural PHs.

View Article and Find Full Text PDF
Article Synopsis
  • The study examined how outpatient oral loop diuretic dose changes affect the health outcomes of heart failure patients, following 679 individuals between 2015 and 2019.
  • It categorized patients into three groups based on their diuretic dose: no reduction, single reduction, and successive reductions, finding that fewer deaths and heart failure hospitalizations were linked to dose reductions.
  • Ultimately, the research concluded that reducing loop diuretic doses can be a sign of better prognosis for patients with heart failure.
View Article and Find Full Text PDF

Background: Approximately 10% of hypertrophic cardiomyopathy (HCM) patients have left ventricular systolic dysfunction (end-stage HCM) leading to severe heart-failure; however, risk stratification to identify patients at risk of progressing to end-stage HCM remains insufficient.

Objectives: In this study, the authors sought to elucidate whether the coexistence of other cardiovascular disease (CVD)-related variants is associated with progression to end-stage HCM in patients with HCM harboring pathogenic or likely pathogenic (P/LP) sarcomeric variants.

Methods: The authors performed genetic analysis of 83 CVD-related genes in HCM patients from a Japanese multicenter cohort.

View Article and Find Full Text PDF
Article Synopsis
  • * Out of 1474 patients analyzed, 18.4% received higher doses of beta-blockers one month post-surgery, showing a significant association with lower risks of all-cause and cardiovascular mortality.
  • * The findings suggest that adjusting beta-blocker therapy after M-TEER can lead to improved outcomes, particularly for patients with a low left ventricular ejection fraction (LVEF) of 40% or less.
View Article and Find Full Text PDF
Article Synopsis
  • - The study investigates how mismatched residual mitral regurgitation (MR) and left atrial pressure (LAP) after a specific heart procedure (TEER) can negatively impact clinical outcomes in patients with severe MR and heart failure.
  • - Researchers categorized 1,477 patients into three groups based on their MR and LAP levels, finding that those with mismatched or poor conditions faced higher risks of death and heart failure hospitalization compared to those in an optimal state.
  • - Six key factors were identified as predictors of hemodynamic mismatch after TEER, including body mass index and pre-procedural pressures, suggesting that monitoring these could help improve patient outcomes.
View Article and Find Full Text PDF

Aims: Mitral transcatheter edge-to-edge repair (M-TEER) is a valid treatment option for severe mitral regurgitation (MR), necessitating accurate risk stratification of M-TEER candidates for effective patient selection, optimal periprocedural care and improved long-term outcomes. The body mass index (BMI) is a simple and practical prognostic index, and the obesity paradox has been widely reported.

Methods And Results: Between April 2018 and June 2021, 2149 patients undergoing M-TEER were registered in the prospective multicentre registry and classified into three groups: underweight (BMI < 18.

View Article and Find Full Text PDF
Article Synopsis
  • * The study compares a new treatment technique, high-power short-duration pulmonary vein isolation (HPSD-PVI), with traditional methods to see which is more effective in preventing recurrent atrial tachyarrhythmia (ATA).
  • * Analyzing 969 patients, the research found that different factors predicted recurrence for each technique, with the HPSD-PVI group showing a trend towards lower recurrence rates compared to the conventional method.
View Article and Find Full Text PDF

Aim: The unique feature of Fontan circulation is elevated central venous pressure, which causes Fontan-associated liver disease (FALD). FALD is associated with a high incidence of hepatocellular carcinoma (HCC). Performing biopsies in patients with FALD is difficult as a result of warfarinization; gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid (Gd-EOB-DTPA)-enhanced magnetic resonance imaging (MRI), a noninvasive examination, is useful for characterizing liver disease and detecting HCC.

View Article and Find Full Text PDF
Article Synopsis
  • Clonal hematopoiesis of indeterminate potential (CHIP) is shown to worsen outcomes in patients with nonischemic dilated cardiomyopathy (DCM) despite being well-known for its negative impacts on atherosclerotic disease.
  • Researchers analyzed 198 DCM patients using advanced genetic sequencing to find both germline mutations linked to cardiomyopathy and somatic mutations in CHIP driver genes, discovering 25 CHIP mutations in 22 patients.
  • The study concluded that CHIP is an independent risk factor for cardiac issues in DCM, contributing to worsened heart function and structural damage, and that genetic mutations can help predict patient prognosis.
View Article and Find Full Text PDF

Background: This study investigated whether intensive lipid-lowering therapy with pitavastatin and ezetimibe lowers the incidence of heart failure (HF) events in patients with acute coronary syndrome (ACS).

Methods And Results: In the HIJ-PROPER study, 1,734 patients with ACS were randomly assigned to either pitavastatin plus ezetimibe therapy (n=864) or pitavastatin monotherapy (n=857). We examined the incidence of HF between these 2 groups over a 3.

View Article and Find Full Text PDF

Background: Although diastolic dysfunction is the main pathophysiological feature of hypertrophic cardiomyopathy (HCM), it remains to be clarified whether parameters of diastolic function can reliably determine HCM prognosis. In patients with reduced left ventricular (LV) distensibility, chronic elevation of LV diastolic pressure is seen with a smaller than expected LV size. Accordingly, patients with HCM with severe LV diastolic dysfunction typically demonstrate left atrial (LA) dilation and a disproportionately smaller left ventricle.

View Article and Find Full Text PDF

Endovascular treatment (EVT) for peripheral artery disease in patients with chronic limb-threatening ischemia (CLTI) is a common practice in contemporary medicine and its effectiveness is widely acknowledged. However, refractory ulcers can occasionally be encountered, particularly in patients who underwent renal transplantation (RT), even after successful EVT. To date, there have been no data on prognosis reported following EVT for CLTI in RT recipients.

View Article and Find Full Text PDF
Article Synopsis
  • Data on patients using temporary mechanical circulatory support (tMCS) highlighted a link between shock severity, classified by the Society for Cardiovascular Angiography and Interventions (SCAI), and the occurrence of bleeding events.
  • In a study of 285 patients, in-hospital bleeding rates increased from 11.1% in stage A to 64.1% in stage E, showing a clear correlation between higher shock stages and bleeding risks.
  • The findings suggest that using the SCAI shock stage can help identify patients at greater risk for bleeding, aiding in more effective clinical management.
View Article and Find Full Text PDF
Article Synopsis
  • * A study was conducted on 19 patients who had implantable cardioverter defibrillators (ICD) placed for primary prevention of SCD, using plasma samples to analyze metabolic profiles before the procedure.
  • * Over a median follow-up of about 29 months, certain metabolites like arginine, lysine, and valine were found to be significantly lower in patients who developed ventricular arrhythmia or SCD, indicating that energy metabolism might play a role in these conditions that warrants further research.
View Article and Find Full Text PDF

Background: Managing heart rate (HR) is crucial for enhancing clinical prognosis in patients with heart failure (HF) and atrial fibrillation (AF). Nevertheless, the prognostic impact of HR at discharge in hospitalized HF patients remains unclear.

Objectives: This study aimed to determine the HR associated with the lowest risk of death and HF in patients hospitalized with HF and AF.

View Article and Find Full Text PDF